rituximab,ocrelizumab
roche,biogen
[]
fantastic to see one of our previous mcdonald fellows - - presenting her work in the late breaking session at #ectrims2022 
Head of Research & Access @MSIntFederation interested in MS, cancer and public health...Views are my own